Northlane Capital Partners Invests in United States Drug Testing Laboratories

Intertek Acquires Professional Testing Laboratory (PTL)

November 26, 2025

Industrial Services

Intertek Group plc has acquired Professional Testing Laboratory, LLC (PTL), a Dalton, Georgia-based provider of flooring products testing services. The acquisition expands Intertek's Total Quality Assurance (TQA) capabilities and regional footprint in the Southeast United States, adding PTL's laboratory, 26 technical staff and complementary services to Intertek's North American testing platform.

UL Solutions Acquires Data Test Labs

June 29, 2022

Industrial Services

UL Solutions has acquired Data Test Labs, a Plymouth, Michigan-based provider of electrical, environmental and mechanical testing services for automakers and their suppliers. The acquisition expands UL Solutions' automotive testing and certification capabilities to provide OEMs and top-tier suppliers with end-to-end validation and safety services.

InTandem Capital Partners Invests in Clinilabs

March 12, 2025

Healthcare Services

InTandem Capital Partners has made a strategic growth investment in Clinilabs, a global full-service contract research organization (CRO) focused exclusively on central nervous system (CNS) drug and device development. The partnership with Clinilabs’ founder and management will support scaling the company’s neuroscience trial capabilities across Phase 1–3 and accelerate commercial and operational growth.

DCA Partners and CVF Capital Acquire Cordant Health Solutions' Toxicology Direct Bill Division

April 10, 2023

Healthcare Services

DCA Partners, with co-investor CVF Capital Partners and financing support from Gladstone Capital, acquired the Toxicology Direct Bill division of Cordant Health Solutions in a carve-out from an unnamed financial institution. The division provides drug testing and medication monitoring services to parole/probation agencies, drug courts and treatment clinics across the United States and will continue operating under the Cordant name.

Premier Biotech Acquires National Test Systems

November 5, 2025

Medical Devices

Premier Biotech, a portfolio company of Align Capital Partners, has acquired National Test Systems (NTS), a provider of rapid point-of-care drug screening supplies and services that serves more than 1,500 facilities across the United States. The acquisition expands Premier's point-of-care testing capabilities (including oral fluid testing) and deepens its presence in government and behavioral health end markets; NTS CEO Andrew Panico will remain involved to support the transition.

Levine Leichtman Capital Partners Acquires NSL Analytical Services

June 28, 2024

Industrial Services

Levine Leichtman Capital Partners (LLCP) has acquired NSL Analytical Services from May River Capital. NSL, a Cleveland-based materials testing and analytical laboratory serving aerospace, advanced materials and electronics markets, will partner with LLCP and management to expand testing capabilities and geographic footprint; financial terms were not disclosed.